S
Sabine M. J. M. Straus
Researcher at Erasmus University Rotterdam
Publications - 83
Citations - 5011
Sabine M. J. M. Straus is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Population & European union. The author has an hindex of 31, co-authored 83 publications receiving 4612 citations. Previous affiliations of Sabine M. J. M. Straus include Utrecht University.
Papers
More filters
Journal ArticleDOI
Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study.
Gysèle S. Bleumink,Anneke M Knetsch,Miriam C. J. M. Sturkenboom,Sabine M. J. M. Straus,Albert Hofman,Jaap W. Deckers,Jacqueline C.M. Witteman,Bruno H. Stricker +7 more
TL;DR: Prevalence and incidence rates of heart failure are high in individuals aged 55, almost 1 in 3 will develop heart failure during their remaining lifespan, and lifetime risk and prognosis are poor.
Journal ArticleDOI
Prolonged QTc interval and risk of sudden cardiac death in a population of older adults
Sabine M. J. M. Straus,Jan A. Kors,Marie L. De Bruin,Cornelis S. van der Hooft,Albert Hofman,Jan Heeringa,Jaap W. Deckers,J. Herre Kingma,Miriam C. J. M. Sturkenboom,Bruno H. Stricker,Jacqueline C.M. Witteman +10 more
TL;DR: Abnormal QTc prolongation on the electrocardiogram should be viewed as an independent risk factor for sudden cardiac death.
Journal ArticleDOI
Antipsychotics and the Risk of Sudden Cardiac Death
Sabine M. J. M. Straus,Gysèle S. Bleumink,Jeanne P. Dieleman,Johan van der Lei,Geert W. ‘t Jong,J. Herre Kingma,Miriam C. J. M. Sturkenboom,Bruno H. Stricker +7 more
TL;DR: Current use of antipsychotics in a general population is associated with an increased risk of sudden cardiac death, even at a low dose and for indications other than schizophrenia.
Journal ArticleDOI
Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death
Sabine M. J. M. Straus,Miriam C. J. M. Sturkenboom,Gysèle S. Bleumink,Jeanne P. Dieleman,Johan van der Lei,Pieter A. de Graeff,Jan Herre Kingma,Bruno H. Stricker +7 more
TL;DR: The use of non-cardiac QTc-prolonging drugs in a general population is associated with an increased risk of sudden cardiac death.
Journal ArticleDOI
Safety-Related Regulatory Actions for Biologicals Approved in the United States and the European Union
Thijs J. Giezen,Aukje K. Mantel-Teeuwisse,Sabine M. J. M. Straus,Huub Schellekens,Hubert G. M. Leufkens,Antoine C. G. Egberts +5 more
TL;DR: The nature of safety problems identified after approval for biologicals is often related to the immunomodulatory effect (infections), and because the biologicals first in class to obtain approval were more likely to be subjected to regulatory action, close monitoring is recommended.